Un groupe basé sur la complémentarité d'expertise avec un savoir-faire pluridisciplinaire


IL1RAP, a therapeutic target for oncologic treatment

Date de publication : 31/07/2020

IL1-RAP, has been identified as a marker of interest in the context of CML treatments, activating NK cells and blocking tumour growth at the same time. Diaclone and Inserm teams  have been able to develop a CAR-T therapy to specifically target this biomarker, which has demonstrated great promise during preclinical studies.

Read more on Linked In

Discover Diaclone's new IL1RAP clones:

Anti-Human IL1RAP B-L43 Azide Free      
Anti-Human IL1RAP B-R58 Azide Free      
Anti-Human IL1RAP B-L43 Unconjugated      
Anti-Human IL1RAP B-R58 Unconjugated      


Another immuno-oncology target you would like to discuss?

Not fully aware of our complete immuno-oncology portfolio

Time to get in touch with the Diaclone team!

    Date de publication : 15/10/2020
    Developed in our laboratories in France   Plus d'info
  • 20 percent discount
    Diaclone - mAbs, ELISA, ELISpot, protéines : Profitez d'une remise de 20%!
    Date de publication : 07/10/2020
  • Covid-19 Toolbox of the mAbexperts group
    Date de publication : 05/08/2020
  • RD-Biotech - Remise sur les kits FastELISA, profitez-en !
    Date de publication : 03/08/2020
  • Anti-S1 Domain Spike Protein is now available at Diaclone
    Date de publication : 03/08/2020

    Ideal for your COVID-19 studies...

    The antibody Anti-SARS-CoV-2 Spike S1 Protein CR3022 recognizes the S1 domain of the SARS-CoV Spike protein (aa318-510) as well as SARS-CoV-2 (COVID-19)...

    Plus d'info
  • IL1RAP, a therapeutic target for oncologic treatment
    Date de publication : 31/07/2020

    IL1-RAP, has been identified as a marker of interest in the context of CML treatments, activating NK cells and blocking tumour growth at the same time. Diaclone and Inserm teams  have been able...

    Plus d'info
  • Do you know the real potential of AAV?
    Date de publication : 01/07/2020

    Revealing the full potential of Adeno Associated Virus thanks to molecular biology

    Adeno-associated virus (AAV) is a small and single-strand DNA virus. In 1960, this non-enveloped entity was...

    Plus d'info
  • What you need to know about Exosomes
    Date de publication : 01/07/2020

    “Huge opportunities”. “Many hurdles”. “Enormous potential”...

    It's just an excerpt of the several terms you'll come across if you search for them on the...

    Plus d'info
  • Complete Proteome of COVID-19
    Date de publication : 15/06/2020

    Are you familiar with all the proteins of SARS-CoV-2?

    Read more on Linked In

    Are you working on any of these proteins?

    Which one would you like to see developed and validated?


    Plus d'info
  • RD-Biotech fournisseur des anticorps monoclonaux murins D1-25 et 1112-1, pour la quantification par ELISA de la glycoprotéine G du virus de la rage
    Date de publication : 15/06/2020

    Signature d’accord de licence avec Institut Pasteur (France) et le Winstar Institute (USA) permettant à RD-Biotech de commercialiser les 2 anticorps monoclonaux murins D1-25 et 1112-1...

    Plus d'info
  • Patients’ Immune Battle Against COVID-19
    Date de publication : 27/05/2020

    A brief review of the expected complications of CovId-19 infection.

    Read more on Linked In

    Diaclone offers a specific range of Antibodies, ELISA and ELISpot kits for COVID-19 research that can...

    Plus d'info
  • Fast track your Covid-19 Research with Diaclone’s CYTOKINES
    Date de publication : 26/05/2020

    Diaclone manufactures essential tools for Cytokine Storm monitoring & Immunotherapy...

    Plus d'info
  • Latest News on COVID-19
    Date de publication : 06/05/2020

    With more than 3,000,000 cases and 200,000 deaths, and after three months of the worldwide outbreak, scientists keep on learning about COVID-19 every day.

    How can people be positively diagnosed...

    Plus d'info
  • RD-Biotech : Here to help you in your Covid-19 related research projects
    Date de publication : 28/04/2020
  • Essential tools for COVID-19 and Immunotherapy research
    Date de publication : 03/04/2020
  • depistage
    RD-BIOTECH produit les anticorps monoclonaux pour le test de dépistage de COVID-19 « Ag Respi-Strip » développé par CorisBioConcept !
    Date de publication : 03/04/2020

    RD-BIOTECH, acteur majeur en France dans la production d’anticorps monoclonaux et de protéines recombinantes est partenaire de la société belge Coris...

    Plus d'info
  • Human IL-6 cytokine, a useful tool for Coronavirus disease (COVID-19) and Immunotherapy research
    Date de publication : 20/03/2020

    DIACLONE provides a large panel of products for the quantification of human IL-6 and other human cytokines.


    Our Human IL-6 range...

    Plus d'info
  • Bispecific Antibody: The Janus God of Therapeutics?
    Date de publication : 18/03/2020

    With 85 molecules under development and 3 approvals to date, it seems that bispecific antibodies may be the novel therapeutic booming class on the market...

    Read more on LinkedIn

    Since its...

    Plus d'info
  • Future
    The Future of Therapeutic Antibody Development
    Date de publication : 12/03/2020

    The mAbexperts team has developed strong expertise in molecular biology to help you generate new formats of monoclonal antibodies.

    Read more on LinkedIn


    mAbexperts is a group...

    Plus d'info
  • Antibody Humanization
    Date de publication : 05/03/2020

    Many articles about antibodies refer to the term “humanization”.  

    But what does humanization mean? What technical approaches are used to carry out such a process? What are the...

    Plus d'info
  • In Gut We Trust... What is the microbiota and how does it influence our health?
    Date de publication : 10/02/2020

    Not a week goes by without a scientific article dealing with the microbiota. And we often hear that understanding the microbiota is explaining our illnesses. But what is exactly the microbiota and...

    Plus d'info
  • Diaclone est partenaire d’un projet européen d’envergure associant une douzaine de partenaires de la région de Besançon
    Date de publication : 21/08/2018

    Le Projet MiMédi

    MIMEDI: MIcrotechnique pour les MEDicaments Innovants nouvelles solutions technologiques pour optimiser la fabrication de "cellules médicaments"

    Au sein...

    Plus d'info